

QUICK LINKS
Deshydroxyethoxy ticagrelor-d7 acts as a potent inhibitor of platelet aggregation. It functions by binding to the P2Y12 receptor on platelets, thereby preventing the activation of this receptor by adenosine diphosphate (ADP). This interaction ultimately inhibits the activation of the glycoprotein IIb/IIIa complex, which is for platelet aggregation and the formation of blood clots. By interfering with this process at the molecular level, deshydroxyethoxy ticagrelor-d7 effectively prevents the initiation and progression of thrombosis. Its mechanism of action involves disrupting the signaling cascade that leads to platelet activation, making it useful for investigating the molecular mechanisms underlying thrombotic events. Deshydroxyethoxy Ticagrelor-d7′s ability to target the P2Y12 receptor without affecting other cellular processes.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Deshydroxyethoxy ticagrelor-d7, 0.5 mg | sc-499501 | 0.5 mg | $396.00 |